KPV 10mg

KPV 10mg — Anti-Inflammatory α-MSH C-Terminal Tripeptide Research Compound

KPV (Lys-Pro-Val) is a tripeptide corresponding to the C-terminal amino acids 11-13 of alpha-melanocyte-stimulating hormone (α-MSH), one of the body’s most potent endogenous anti-inflammatory mediators. Despite being just three amino acids in length, KPV retains remarkable anti-inflammatory potency, demonstrating that the anti-inflammatory signaling domain of α-MSH is concentrated in this minimal C-terminal sequence. This unusually compact size provides clear advantages in tissue penetration, formulation flexibility, and chemical stability under common laboratory conditions, all of which have made KPV an increasingly popular research tool over the last decade within the immune support peptides research category.

Anti-Inflammatory Mechanism

KPV’s primary anti-inflammatory mechanism involves direct inhibition of the nuclear factor kappa-B (NF-κB) signaling pathway, the master transcriptional regulator of inflammatory gene expression. Research has demonstrated that KPV enters cells and interacts with components of the NF-κB cascade, blocking the activation and nuclear translocation events that normally drive pro-inflammatory gene transcription. This intracellular mechanism distinguishes KPV from many other anti-inflammatory peptides that rely solely on extracellular receptor binding.

Gastrointestinal Research Applications

Studies using experimental colitis models have shown that KPV reduces mucosal inflammation, decreases inflammatory cell infiltration, preserves epithelial barrier integrity, and attenuates overall disease severity scores. The peptide’s ability to be administered orally — unusual for peptides — has generated particular interest, as studies have demonstrated anti-inflammatory effects following oral delivery in nanoparticle and hydrogel formulations targeting the gut lumen.

Wound Healing and Antimicrobial Properties

Research has documented KPV’s beneficial effects on wound healing, where its anti-inflammatory activity creates a more favorable environment for tissue repair. Additionally, studies have revealed that KPV possesses direct antimicrobial activity against certain bacterial species, including pathogens relevant to wound infections and gastrointestinal pathology. This dual anti-inflammatory and antimicrobial profile has attracted significant interest from researchers studying infection-associated inflammatory conditions, post-surgical recovery models, and chronic non-healing wound investigations in cell culture and animal systems.

Melanocortin System Research

KPV provides researchers with a tool for studying the anti-inflammatory components of melanocortin signaling independently of the melanogenic, appetite-suppressing, and sexual-function effects associated with full-length α-MSH. This selectivity enables more precise investigation of melanocortin anti-inflammatory pathways and isolated receptor-subtype contributions in cell culture and animal models, enabling cleaner experimental designs when isolating individual signaling arms of the broader melanocortin family.

Cytokine and Oxidative-Stress Studies

Beyond NF-κB, KPV has been studied for its modulation of pro-inflammatory cytokines such as TNF-α, IL-1β, and IL-8, with measurable suppression observed in stimulated immune cell cultures. Researchers have also reported reductions in reactive oxygen species, supporting investigations into how KPV interacts with oxidative-stress signaling alongside its primary anti-inflammatory action.

Comparison With Related Immune Peptides

KPV is frequently studied alongside other immune-modulating peptides such as Thymosin Alpha-1 and VIP, allowing researchers to compare melanocortin-derived signalling against thymic and vasoactive intestinal pathways. These parallel studies help build a more complete picture of how individual immune-support peptides influence different arms of the inflammatory response.

Quality, Storage, and Compliance

Each vial of KPV 10mg is manufactured to 99%+ HPLC-verified purity and supplied as a sterile lyophilized powder. Store unreconstituted vials at -20°C; reconstituted material should be refrigerated at 2–8°C. This KPV product is sold strictly for in-vitro laboratory research only. Not for human consumption, diagnostic use, or any clinical application. Buyers must comply with all applicable provincial and federal regulations.